{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T10:50:26Z","timestamp":1789383026571,"version":"build-2803163510"},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1097\/fpc.0b013e3283307cf1","type":"journal-article","created":{"date-parts":[[2009,9,3]],"date-time":"2009-09-03T03:16:41Z","timestamp":1251947801000},"page":"730-733","source":"Crossref","is-referenced-by-count":33,"title":["Weight loss and body fat reduction under sibutramine therapy in obesity with the C825T polymorphism in the GNB3 gene"],"prefix":"10.1097","volume":"19","author":[{"given":"Dun-Jen","family":"Hsiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence Shih-Hsin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Yi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20210212","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.ahj.2005.03.006","article-title":"Clinical trial issues in weight-loss therapy","volume":"151","author":"Patel","year":"2006","journal-title":"Am Heart J"},{"key":"R2-9-20210212","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1517\/14656566.9.12.2161","article-title":"Sibutramine: current status as an anti-obesity drug and its future perspectives","volume":"9","author":"Sharma","year":"2008","journal-title":"Expert Opin Pharmacother"},{"key":"R3-9-20210212","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/00008571-200308000-00003","article-title":"Prediction of successful weight reduction under sibutramine therapy through genotyping of the G-protein beta3 subunit gene (GNB3) C825T polymorphism","volume":"13","author":"Hauner","year":"2003","journal-title":"Pharmacogenetics"},{"key":"R4-9-20210212","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.cgh.2007.02.037","article-title":"Alteration of gastric functions and candidate genes associated with weight reduction in response to sibutramine","volume":"5","author":"Vazquez Roque","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R5-9-20210212","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1053\/j.gastro.2008.07.009","article-title":"A controlled pharmacogenetic trial of sibutramine on weight loss and body composition in obese or overweight adults","volume":"135","author":"Grudell","year":"2008","journal-title":"Gastroenterology"},{"key":"R6-9-20210212","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1074\/jbc.273.2.669","article-title":"The many faces of G protein signaling","volume":"273","author":"Hamm","year":"1998","journal-title":"J Biol Chem"},{"key":"R7-9-20210212","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1146\/annurev.med.56.082103.104625","article-title":"G protein polymorphisms in hypertension, atherosclerosis, and diabetes","volume":"56","author":"Siffert","year":"2005","journal-title":"Annu Rev Med"},{"key":"R8-9-20210212","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1440-1681.2006.04353.x","article-title":"Hypertension, obesity and GNB 3 gene variants","volume":"33","author":"Danoviz","year":"2006","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"R9-9-20210212","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.2337\/diacare.27.5.1182","article-title":"Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians?","volume":"27","author":"Tan","year":"2004","journal-title":"Diabetes Care"},{"key":"R10-9-20210212","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/ng0198-45","article-title":"Association of a human G-protein beta3 subunit variant with hypertension","volume":"18","author":"Siffert","year":"1998","journal-title":"Nat Genet"}],"container-title":["Pharmacogenetics and Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01213011-200909000-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:06:16Z","timestamp":1786039576000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01213011-200909000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":10,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/fpc.0b013e3283307cf1","relation":{},"ISSN":["1744-6872"],"issn-type":[{"value":"1744-6872","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}